An ImmunoChip study of multiple sclerosis risk in African Americans

Brain

Volumn 138, Issue 6, 2015, Pages 1518-1530

  Isobe, Noriko ^a,b   Madireddy, Lohith ^a   Khankhanian, Pouya ^a   Matsushita, Takuya ^a,c   Caillier, Stacy J ^a   Moré, Jayaji M ^a   Gourraud, Pierre Antoine ^a   McCauley, Jacob L ^d   Beecham, Ashley H ^d   Piccio, Laura ^e   Herbert, Joseph ^f   Khan, Omar ^g   Cohen, Jeffrey ^h   Stone, Lael ^h   Santaniello, Adam ^a   Cree, Bruce A C ^a   Onengut Gumuscu, Suna ⁱ   Rich, Stephen S ⁱ   Hauser, Stephen L ^a   Sawcer, Stephen ^j   Oksenberg, Jorge R ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAGA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j Cambridge Biomedical Campus ^*  (United Kingdom)

more..

Author keywords

African Americans; ImmunoChip; Linkage disequilibrium; Multiple sclerosis

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

AFRICAN AMERICAN; ALLELE; ARTICLE; AUTOSOME; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EUROPEAN; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; ONE TAILED TEST; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; DNA MICROARRAY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

AFRICAN AMERICANS; ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84943165393     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv078     Document Type: Article

References (63)

1. Bachmann MP, Bartsch H, Gross JK, Maier SM, Gross TF, Workman JL, et al. Autoimmunity as a result of escape from RNA surveillance. J Immunol 2006; 177: 1698-707
2. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M An integrated encyclopedia of DNA elements in the human genome Nature 2012; 489: 57-74
3. Boster AL, Endress CF, Hreha SA, Caon C, Perumal JS, Khan OA Pediatric-onset multiple sclerosis in African-American black and European-origin white patients. Pediatr Neurol 2009; 40: 31-3
4. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012; 22: 1790-7
5. Buchanan RJ, Martin RA, Zuniga M, Wang S, Kim M. Nursing home residents with multiple sclerosis: comparisons of African American residents to white residents at admission. Mult Scler 2004; 10: 660-7
6. Buyske S, Wu Y, Carty CL, Cheng I, Assimes TL, Dumitrescu L, et al Evaluation of the metabochip genotyping array in African Americans and implications for fine mapping of GWAS-identified loci: the PAGE study. PLoS One 2012; 7: e35651
7. Clarke GM, Cardon LR. Aspects of observing and claiming allele flips in association studies. Genet Epidemiol 2010; 34: 266-74
8. Cooper JD, Simmonds MJ, Walker NM, Burren O, Brand OJ, Guo H, et al. Seven newly identified loci for autoimmune thyroid disease Hum Mol Genet 2012; 21: 5202-8
9. Cortes A, Brown MA. Promise and pitfalls of the Immunochip Arthritis Res Ther 2011; 13: 101
10. Cotsapas C, Voight BF, Rossin E, Lage K, Neale BM, Wallace C, et al Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011; 7: e1002254
11. Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G, et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 2011; 134: 693-703
12. Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004; 63: 2039-45
13. Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, et al. Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. Arch Neurol 2009; 66: 226-33
14. Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvanen AC, Ronnblom L, et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 2011; 7: e1002341
15. Dayem Ullah AZ, Lemoine NR, Chelala C. A practical guide for the functional annotation of genetic variations using SNPnexus. Brief Bioinform 2013; 14: 437-47
16. Diabetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, and Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2DGENES) ConsortiumGenome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 2014; 46: 234-44
17. Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P, et al. Highdensity genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012; 44: 1336-40
18. Freeman C, Marchini J. GTOOL. 2007. http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html
19. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus Nat Genet 2009; 41: 1228-33
20. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, Lai SL, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010; 6: e1000952
21. Gong J, Schumacher F, Lim U, Hindorff LA, Haessler J, Buyske S, et al. Fine Mapping and Identification of BMI Loci in African Americans. Am J Hum Genet 2013; 93: 661-71
22. Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F, et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012; 488: 508-11
23. Hauser SL, Goodin DS. Multiple Sclerosis and other demyelinating diseases. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's principle of internal medicine. 18th edn. New York: McGraw Hill; 2012 p. 3395-409
24. Hinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, et al Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013; 45: 664-9
25. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529
26. International Multiple Sclerosis Genetics Consortium (IMSGC) Network-based multiple sclerosis pathway analysis with GWAS data from 15, 000 cases and 30, 000 controls. Am J Hum Genet 2013a; 92: 854-65
27. International Multiple Sclerosis Genetics Consortium (IMSGC) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013b; 45: 1353-60
28. International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-9
29. Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology 2013; 81: 219-27
30. Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, et al Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci USA 2012; 109: E59-67
31. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-24
32. Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, et al. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants Hum Mol Genet 2012; 21: 5209-21
33. Kimbrough DJ, Sotirchos ES, Wilson JA, Al-Louzi O, Conger A, Conger D, et al. Retinal damage and vision loss in African-American multiple sclerosis patients. Ann Neurol 2014; 77: 228-36
34. Kim-Howard X, Sun C, Molineros JE, Maiti AK, Chandru H, Adler A, et al. Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. Hum Mol Genet 2014; 23: 1656-68
35. Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology 2013; 80: 1734-9
36. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007; 80: 531-8
37. Liu JZ, Almarri MA, Gaffney DJ, Mells GF, Jostins L, Cordell HJ, et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet 2012; 44: 1137-41
38. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109: 3879-84
39. Maier LM, Anderson DE, Severson CA, Baecher-Allan C, Healy B, Liu DV, et al. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J Immunol 2009; 182: 1541-7
40. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010; 11: 499-511
41. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7
42. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298-303
43. Oksenberg JR, Baranzini SE. Multiple sclerosis genetics-is the glass half full, or half empty? Nat Rev Neurol 2010; 6: 429-37
44. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004; 74: 160-7
45. Pandit L, Ban M, Sawcer S, Singhal B, Nair S, Radhakrishnan K, et al Evaluation of the established non-MHC multiple sclerosis loci in an Indian population. Mult Scler 2011; 17: 139-43
46. Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897-912
47. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302
48. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26: 2336-7
49. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75
50. Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A, et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 2005; 37: 1113-8
51. Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol 2014; 13: 700-9
52. Simon KC, Munger KL, Ascherio A. XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented? J Neurol Sci 2011; 311: 1-8
53. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, et al Population genomics of human gene expression. Nat Genet 2007; 39: 1217-24
54. The 1000 Genomes Project ConsortiumA map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-73
55. Tishkoff SA, Kidd KK. Implications of biogeography of human populations for 'race' and medicine. Nat Genet 2004; 36: S21-7
56. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011; 43: 1193-201
57. Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, et al Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012; 44: 1341-8
58. Wallin MT, Culpepper WJ, Coffman P, Pulaski S, Maloni H, Mahan CM, et al. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain 2012; 135: 1778-85
59. Wallin MT, Page WF, Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography Ann Neurol 2004; 55: 65-71
60. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164
61. Warnes G, Duffy D, Man M, Qiu W, Lazarus R. GeneticsDesign: Functions for designing genetics studies. R package version 1.28.0 2010. http://www.bioconductor.org/packages/release/bioc/html/Gen eticsDesign.html
62. Zaykin DV, Shibata K. Genetic flip-flop without an accompanying change in linkage disequilibrium. Am J Hum Genet 2008; 82: 794-6
63. Zheng X, Levine D, Shen J, Gogarten SM, Laurie C, Weir BS. A highperformance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics 2012; 28: 3326-8.